The future of COVID-19 management: A spotlight on respirology
10 Jan 2024;
At the 27th Congress of the Asian Pacific Society of Respirology (APSR) 2023, a Pfizer-sponsored symposium addressed the evolving challenges of COVID-19, particularly for patients with pre-existing respiratory conditions. Chaired by Dr Chan Kwok Wai Adrian, a renowned respiratory physician and intensivist from Mount Elizabeth Novena Hospital, Singapore, and featuring insights from Professor Yang Kuang-Yao of National Yang Ming Chiao Tung University, Taipei, Taiwan, the symposium focused on the disease’s impact, treatment guidelines, regional management strategies, and the role of nirmatrelvir/ritonavir, a new oral combination pill, in the treatment of COVID-19.
Sign Out
%20%e0%b8%97%e0%b8%b5%e0%b9%88%e0%b8%a1%e0%b8%b5%e0%b8%a0%e0%b8%b2%e0%b8%a7%e0%b8%b0%20statin%20intolerance.jpg)
